← 產業報告目錄
Oxcarbazepine Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 149報告編號 APO-6e60f5909a
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Oxcarbazepine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxcarbazepine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxcarbazepine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Oxcarbazepine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxcarbazepine include Sihuan Pharm, Humanwell Healthcare, Novartis (Trileptal), Mylan, Huikang Pharmaceutical, Teva Pharmaceutical, Taro Pharmaceuticals, Supernus Pharmaceuticals (Oxtellar XR) and Sun Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxcarbazepine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxcarbazepine Market by Company
Sihuan Pharm
Humanwell Healthcare
Novartis (Trileptal)
Mylan
Huikang Pharmaceutical
Teva Pharmaceutical
Taro Pharmaceuticals
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Stada Group
Roxane Laboratories
Ranbaxy Pharmaceuticals
Orion Corporation
Nobelpharma
Nexgen pharma
Neuraxpharm
Jubilant Generics
Jamp Pharma
Hikma Pharmaceuticals
Glenmark Pharmaceuticals
Apotex
ANI Pharmaceuticals
Amneal Pharmaceuticals
Oxcarbazepine Segment by Type
Tablets (150mg, 300mg, 600mg)
Oral Suspension
Oxcarbazepine Segment by Application
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use
Oxcarbazepine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxcarbazepine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxcarbazepine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxcarbazepine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxcarbazepine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxcarbazepine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxcarbazepine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oxcarbazepine Market Size (2021-2032)
2.2.2 Global Oxcarbazepine Sales (2021-2032)
2.2.3 Global Oxcarbazepine Market Average Price (2021-2032)
2.3 Oxcarbazepine by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Tablets (150mg, 300mg, 600mg)
2.3.3 Oral Suspension
2.4 Oxcarbazepine by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Pediatric Use (Aged 2-4 years, 4-16 years)
2.4.3 Adult Use
3 Market Competitive Landscape by Manufacturers
3.1 Global Oxcarbazepine Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Oxcarbazepine Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Oxcarbazepine Revenue of Manufacturers (2021-2026)
3.4 Global Oxcarbazepine Average Price by Manufacturers (2021-2026)
3.5 Global Oxcarbazepine Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Oxcarbazepine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oxcarbazepine, Product Type & Application
3.8 Global Manufacturers of Oxcarbazepine, Established Date
3.9 Global Oxcarbazepine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Sihuan Pharm
4.1.1 Sihuan Pharm Company Information
4.1.2 Sihuan Pharm Business Overview
4.1.3 Sihuan Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Sihuan Pharm Oxcarbazepine Product Portfolio
4.1.5 Sihuan Pharm Recent Developments
4.2 Humanwell Healthcare
4.2.1 Humanwell Healthcare Company Information
4.2.2 Humanwell Healthcare Business Overview
4.2.3 Humanwell Healthcare Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Humanwell Healthcare Oxcarbazepine Product Portfolio
4.2.5 Humanwell Healthcare Recent Developments
4.3 Novartis (Trileptal)
4.3.1 Novartis (Trileptal) Company Information
4.3.2 Novartis (Trileptal) Business Overview
4.3.3 Novartis (Trileptal) Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Novartis (Trileptal) Oxcarbazepine Product Portfolio
4.3.5 Novartis (Trileptal) Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Business Overview
4.4.3 Mylan Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Mylan Oxcarbazepine Product Portfolio
4.4.5 Mylan Recent Developments
4.5 Huikang Pharmaceutical
4.5.1 Huikang Pharmaceutical Company Information
4.5.2 Huikang Pharmaceutical Business Overview
4.5.3 Huikang Pharmaceutical Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Huikang Pharmaceutical Oxcarbazepine Product Portfolio
4.5.5 Huikang Pharmaceutical Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Company Information
4.6.2 Teva Pharmaceutical Business Overview
4.6.3 Teva Pharmaceutical Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Teva Pharmaceutical Oxcarbazepine Product Portfolio
4.6.5 Teva Pharmaceutical Recent Developments
4.7 Taro Pharmaceuticals
4.7.1 Taro Pharmaceuticals Company Information
4.7.2 Taro Pharmaceuticals Business Overview
4.7.3 Taro Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Taro Pharmaceuticals Oxcarbazepine Product Portfolio
4.7.5 Taro Pharmaceuticals Recent Developments
4.8 Supernus Pharmaceuticals (Oxtellar XR)
4.8.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information
4.8.2 Supernus Pharmaceuticals (Oxtellar XR) Business Overview
4.8.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Portfolio
4.8.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
4.9 Sun Pharm
4.9.1 Sun Pharm Company Information
4.9.2 Sun Pharm Business Overview
4.9.3 Sun Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Sun Pharm Oxcarbazepine Product Portfolio
4.9.5 Sun Pharm Recent Developments
4.10 Stada Group
4.10.1 Stada Group Company Information
4.10.2 Stada Group Business Overview
4.10.3 Stada Group Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Stada Group Oxcarbazepine Product Portfolio
4.10.5 Stada Group Recent Developments
4.11 Roxane Laboratories
4.11.1 Roxane Laboratories Company Information
4.11.2 Roxane Laboratories Business Overview
4.11.3 Roxane Laboratories Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Roxane Laboratories Oxcarbazepine Product Portfolio
4.11.5 Roxane Laboratories Recent Developments
4.12 Ranbaxy Pharmaceuticals
4.12.1 Ranbaxy Pharmaceuticals Company Information
4.12.2 Ranbaxy Pharmaceuticals Business Overview
4.12.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Ranbaxy Pharmaceuticals Oxcarbazepine Product Portfolio
4.12.5 Ranbaxy Pharmaceuticals Recent Developments
4.13 Orion Corporation
4.13.1 Orion Corporation Company Information
4.13.2 Orion Corporation Business Overview
4.13.3 Orion Corporation Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Orion Corporation Oxcarbazepine Product Portfolio
4.13.5 Orion Corporation Recent Developments
4.14 Nobelpharma
4.14.1 Nobelpharma Company Information
4.14.2 Nobelpharma Business Overview
4.14.3 Nobelpharma Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Nobelpharma Oxcarbazepine Product Portfolio
4.14.5 Nobelpharma Recent Developments
4.15 Nexgen pharma
4.15.1 Nexgen pharma Company Information
4.15.2 Nexgen pharma Business Overview
4.15.3 Nexgen pharma Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Nexgen pharma Oxcarbazepine Product Portfolio
4.15.5 Nexgen pharma Recent Developments
4.16 Neuraxpharm
4.16.1 Neuraxpharm Company Information
4.16.2 Neuraxpharm Business Overview
4.16.3 Neuraxpharm Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Neuraxpharm Oxcarbazepine Product Portfolio
4.16.5 Neuraxpharm Recent Developments
4.17 Jubilant Generics
4.17.1 Jubilant Generics Company Information
4.17.2 Jubilant Generics Business Overview
4.17.3 Jubilant Generics Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Jubilant Generics Oxcarbazepine Product Portfolio
4.17.5 Jubilant Generics Recent Developments
4.18 Jamp Pharma
4.18.1 Jamp Pharma Company Information
4.18.2 Jamp Pharma Business Overview
4.18.3 Jamp Pharma Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Jamp Pharma Oxcarbazepine Product Portfolio
4.18.5 Jamp Pharma Recent Developments
4.19 Hikma Pharmaceuticals
4.19.1 Hikma Pharmaceuticals Company Information
4.19.2 Hikma Pharmaceuticals Business Overview
4.19.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Hikma Pharmaceuticals Oxcarbazepine Product Portfolio
4.19.5 Hikma Pharmaceuticals Recent Developments
4.20 Glenmark Pharmaceuticals
4.20.1 Glenmark Pharmaceuticals Company Information
4.20.2 Glenmark Pharmaceuticals Business Overview
4.20.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.20.4 Glenmark Pharmaceuticals Oxcarbazepine Product Portfolio
4.20.5 Glenmark Pharmaceuticals Recent Developments
4.21 Apotex
4.21.1 Apotex Company Information
4.21.2 Apotex Business Overview
4.21.3 Apotex Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.21.4 Apotex Oxcarbazepine Product Portfolio
4.21.5 Apotex Recent Developments
4.22 ANI Pharmaceuticals
4.22.1 ANI Pharmaceuticals Company Information
4.22.2 ANI Pharmaceuticals Business Overview
4.22.3 ANI Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.22.4 ANI Pharmaceuticals Oxcarbazepine Product Portfolio
4.22.5 ANI Pharmaceuticals Recent Developments
4.23 Amneal Pharmaceuticals
4.23.1 Amneal Pharmaceuticals Company Information
4.23.2 Amneal Pharmaceuticals Business Overview
4.23.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2021-2026)
4.23.4 Amneal Pharmaceuticals Oxcarbazepine Product Portfolio
4.23.5 Amneal Pharmaceuticals Recent Developments
5 Global Oxcarbazepine Market Scenario by Region
5.1 Global Oxcarbazepine Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Oxcarbazepine Sales by Region: 2021-2032
5.2.1 Global Oxcarbazepine Sales by Region: 2021-2026
5.2.2 Global Oxcarbazepine Sales by Region: 2027-2032
5.3 Global Oxcarbazepine Revenue by Region: 2021-2032
5.3.1 Global Oxcarbazepine Revenue by Region: 2021-2026
5.3.2 Global Oxcarbazepine Revenue by Region: 2027-2032
5.4 North America Oxcarbazepine Market Facts & Figures by Country
5.4.1 North America Oxcarbazepine Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Oxcarbazepine Sales by Country (2021-2032)
5.4.3 North America Oxcarbazepine Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Oxcarbazepine Market Facts & Figures by Country
5.5.1 Europe Oxcarbazepine Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Oxcarbazepine Sales by Country (2021-2032)
5.5.3 Europe Oxcarbazepine Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Oxcarbazepine Market Facts & Figures by Country
5.6.1 Asia Pacific Oxcarbazepine Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Oxcarbazepine Sales by Country (2021-2032)
5.6.3 Asia Pacific Oxcarbazepine Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Oxcarbazepine Market Facts & Figures by Country
5.7.1 South America Oxcarbazepine Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Oxcarbazepine Sales by Country (2021-2032)
5.7.3 South America Oxcarbazepine Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oxcarbazepine Market Facts & Figures by Country
5.8.1 Middle East and Africa Oxcarbazepine Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Oxcarbazepine Sales by Country (2021-2032)
5.8.3 Middle East and Africa Oxcarbazepine Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Oxcarbazepine Sales by Type (2021-2032)
6.1.1 Global Oxcarbazepine Sales by Type (2021-2032) & (K Units)
6.1.2 Global Oxcarbazepine Sales Market Share by Type (2021-2032)
6.2 Global Oxcarbazepine Revenue by Type (2021-2032)
6.2.1 Global Oxcarbazepine Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Oxcarbazepine Revenue Market Share by Type (2021-2032)
6.3 Global Oxcarbazepine Price by Type (2021-2032)
7 Segment by Application
7.1 Global Oxcarbazepine Sales by Application (2021-2032)
7.1.1 Global Oxcarbazepine Sales by Application (2021-2032) & (K Units)
7.1.2 Global Oxcarbazepine Sales Market Share by Application (2021-2032)
7.2 Global Oxcarbazepine Revenue by Application (2021-2032)
7.2.1 Global Oxcarbazepine Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Oxcarbazepine Revenue Market Share by Application (2021-2032)
7.3 Global Oxcarbazepine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Oxcarbazepine Value Chain Analysis
8.1.1 Oxcarbazepine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oxcarbazepine Production Mode & Process
8.2 Oxcarbazepine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oxcarbazepine Distributors
8.2.3 Oxcarbazepine Customers
9 Global Oxcarbazepine Analyzing Market Dynamics
9.1 Oxcarbazepine Industry Trends
9.2 Oxcarbazepine Industry Drivers
9.3 Oxcarbazepine Industry Opportunities and Challenges
9.4 Oxcarbazepine Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Oxcarbazepine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Oxcarbazepine Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Oxcarbazepine Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Oxcarbazepine Revenue of Manufacturers (2021-2026)
Table 9. Global Oxcarbazepine Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Oxcarbazepine Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Oxcarbazepine Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Oxcarbazepine, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Oxcarbazepine, Product Type & Application
Table 14. Global Oxcarbazepine Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Oxcarbazepine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Sihuan Pharm Company Information
Table 19. Sihuan Pharm Business Overview
Table 20. Sihuan Pharm Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Sihuan Pharm Oxcarbazepine Product Portfolio
Table 22. Sihuan Pharm Recent Developments
Table 23. Humanwell Healthcare Company Information
Table 24. Humanwell Healthcare Business Overview
Table 25. Humanwell Healthcare Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Humanwell Healthcare Oxcarbazepine Product Portfolio
Table 27. Humanwell Healthcare Recent Developments
Table 28. Novartis (Trileptal) Company Information
Table 29. Novartis (Trileptal) Business Overview
Table 30. Novartis (Trileptal) Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Novartis (Trileptal) Oxcarbazepine Product Portfolio
Table 32. Novartis (Trileptal) Recent Developments
Table 33. Mylan Company Information
Table 34. Mylan Business Overview
Table 35. Mylan Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Mylan Oxcarbazepine Product Portfolio
Table 37. Mylan Recent Developments
Table 38. Huikang Pharmaceutical Company Information
Table 39. Huikang Pharmaceutical Business Overview
Table 40. Huikang Pharmaceutical Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Huikang Pharmaceutical Oxcarbazepine Product Portfolio
Table 42. Huikang Pharmaceutical Recent Developments
Table 43. Teva Pharmaceutical Company Information
Table 44. Teva Pharmaceutical Business Overview
Table 45. Teva Pharmaceutical Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Teva Pharmaceutical Oxcarbazepine Product Portfolio
Table 47. Teva Pharmaceutical Recent Developments
Table 48. Taro Pharmaceuticals Company Information
Table 49. Taro Pharmaceuticals Business Overview
Table 50. Taro Pharmaceuticals Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Taro Pharmaceuticals Oxcarbazepine Product Portfolio
Table 52. Taro Pharmaceuticals Recent Developments
Table 53. Supernus Pharmaceuticals (Oxtellar XR) Company Information
Table 54. Supernus Pharmaceuticals (Oxtellar XR) Business Overview
Table 55. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Portfolio
Table 57. Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
Table 58. Sun Pharm Company Information
Table 59. Sun Pharm Business Overview
Table 60. Sun Pharm Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Sun Pharm Oxcarbazepine Product Portfolio
Table 62. Sun Pharm Recent Developments
Table 63. Stada Group Company Information
Table 64. Stada Group Business Overview
Table 65. Stada Group Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Stada Group Oxcarbazepine Product Portfolio
Table 67. Stada Group Recent Developments
Table 68. Roxane Laboratories Company Information
Table 69. Roxane Laboratories Business Overview
Table 70. Roxane Laboratories Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Roxane Laboratories Oxcarbazepine Product Portfolio
Table 72. Roxane Laboratories Recent Developments
Table 73. Ranbaxy Pharmaceuticals Company Information
Table 74. Ranbaxy Pharmaceuticals Business Overview
Table 75. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Ranbaxy Pharmaceuticals Oxcarbazepine Product Portfolio
Table 77. Ranbaxy Pharmaceuticals Recent Developments
Table 78. Orion Corporation Company Information
Table 79. Orion Corporation Business Overview
Table 80. Orion Corporation Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Orion Corporation Oxcarbazepine Product Portfolio
Table 82. Orion Corporation Recent Developments
Table 83. Nobelpharma Company Information
Table 84. Nobelpharma Business Overview
Table 85. Nobelpharma Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Nobelpharma Oxcarbazepine Product Portfolio
Table 87. Nobelpharma Recent Developments
Table 88. Nexgen pharma Company Information
Table 89. Nexgen pharma Business Overview
Table 90. Nexgen pharma Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Nexgen pharma Oxcarbazepine Product Portfolio
Table 92. Nexgen pharma Recent Developments
Table 93. Neuraxpharm Company Information
Table 94. Neuraxpharm Business Overview
Table 95. Neuraxpharm Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Neuraxpharm Oxcarbazepine Product Portfolio
Table 97. Neuraxpharm Recent Developments
Table 98. Jubilant Generics Company Information
Table 99. Jubilant Generics Business Overview
Table 100. Jubilant Generics Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Jubilant Generics Oxcarbazepine Product Portfolio
Table 102. Jubilant Generics Recent Developments
Table 103. Jamp Pharma Company Information
Table 104. Jamp Pharma Business Overview
Table 105. Jamp Pharma Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Jamp Pharma Oxcarbazepine Product Portfolio
Table 107. Jamp Pharma Recent Developments
Table 108. Hikma Pharmaceuticals Company Information
Table 109. Hikma Pharmaceuticals Business Overview
Table 110. Hikma Pharmaceuticals Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Hikma Pharmaceuticals Oxcarbazepine Product Portfolio
Table 112. Hikma Pharmaceuticals Recent Developments
Table 113. Glenmark Pharmaceuticals Company Information
Table 114. Glenmark Pharmaceuticals Business Overview
Table 115. Glenmark Pharmaceuticals Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Glenmark Pharmaceuticals Oxcarbazepine Product Portfolio
Table 117. Glenmark Pharmaceuticals Recent Developments
Table 118. Apotex Company Information
Table 119. Apotex Business Overview
Table 120. Apotex Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Apotex Oxcarbazepine Product Portfolio
Table 122. Apotex Recent Developments
Table 123. ANI Pharmaceuticals Company Information
Table 124. ANI Pharmaceuticals Business Overview
Table 125. ANI Pharmaceuticals Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. ANI Pharmaceuticals Oxcarbazepine Product Portfolio
Table 127. ANI Pharmaceuticals Recent Developments
Table 128. Amneal Pharmaceuticals Company Information
Table 129. Amneal Pharmaceuticals Business Overview
Table 130. Amneal Pharmaceuticals Oxcarbazepine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Amneal Pharmaceuticals Oxcarbazepine Product Portfolio
Table 132. Amneal Pharmaceuticals Recent Developments
Table 133. Global Oxcarbazepine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 134. Global Oxcarbazepine Sales by Region (2021-2026) & (K Units)
Table 135. Global Oxcarbazepine Sales Market Share by Region (2021-2026)
Table 136. Global Oxcarbazepine Sales by Region (2027-2032) & (K Units)
Table 137. Global Oxcarbazepine Sales Market Share by Region (2027-2032)
Table 138. Global Oxcarbazepine Revenue by Region (2021-2026) & (US$ Million)
Table 139. Global Oxcarbazepine Revenue Market Share by Region (2021-2026)
Table 140. Global Oxcarbazepine Revenue by Region (2027-2032) & (US$ Million)
Table 141. Global Oxcarbazepine Revenue Market Share by Region (2027-2032)
Table 142. North America Oxcarbazepine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. North America Oxcarbazepine Sales by Country (2021-2026) & (K Units)
Table 144. North America Oxcarbazepine Sales by Country (2027-2032) & (K Units)
Table 145. North America Oxcarbazepine Revenue by Country (2021-2026) & (US$ Million)
Table 146. North America Oxcarbazepine Revenue by Country (2027-2032) & (US$ Million)
Table 147. Europe Oxcarbazepine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. Europe Oxcarbazepine Sales by Country (2021-2026) & (K Units)
Table 149. Europe Oxcarbazepine Sales by Country (2027-2032) & (K Units)
Table 150. Europe Oxcarbazepine Revenue by Country (2021-2026) & (US$ Million)
Table 151. Europe Oxcarbazepine Revenue by Country (2027-2032) & (US$ Million)
Table 152. Asia Pacific Oxcarbazepine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Asia Pacific Oxcarbazepine Sales by Country (2021-2026) & (K Units)
Table 154. Asia Pacific Oxcarbazepine Sales by Country (2027-2032) & (K Units)
Table 155. Asia Pacific Oxcarbazepine Revenue by Country (2021-2026) & (US$ Million)
Table 156. Asia Pacific Oxcarbazepine Revenue by Country (2027-2032) & (US$ Million)
Table 157. South America Oxcarbazepine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. South America Oxcarbazepine Sales by Country (2021-2026) & (K Units)
Table 159. South America Oxcarbazepine Sales by Country (2027-2032) & (K Units)
Table 160. South America Oxcarbazepine Revenue by Country (2021-2026) & (US$ Million)
Table 161. South America Oxcarbazepine Revenue by Country (2027-2032) & (US$ Million)
Table 162. Middle East and Africa Oxcarbazepine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 163. Middle East and Africa Oxcarbazepine Sales by Country (2021-2026) & (K Units)
Table 164. Middle East and Africa Oxcarbazepine Sales by Country (2027-2032) & (K Units)
Table 165. Middle East and Africa Oxcarbazepine Revenue by Country (2021-2026) & (US$ Million)
Table 166. Middle East and Africa Oxcarbazepine Revenue by Country (2027-2032) & (US$ Million)
Table 167. Global Oxcarbazepine Sales by Type (2021-2026) & (K Units)
Table 168. Global Oxcarbazepine Sales by Type (2027-2032) & (K Units)
Table 169. Global Oxcarbazepine Sales Market Share by Type (2021-2026)
Table 170. Global Oxcarbazepine Sales Market Share by Type (2027-2032)
Table 171. Global Oxcarbazepine Revenue by Type (2021-2026) & (US$ Million)
Table 172. Global Oxcarbazepine Revenue by Type (2027-2032) & (US$ Million)
Table 173. Global Oxcarbazepine Revenue Market Share by Type (2021-2026)
Table 174. Global Oxcarbazepine Revenue Market Share by Type (2027-2032)
Table 175. Global Oxcarbazepine Price by Type (2021-2026) & (US$/Unit)
Table 176. Global Oxcarbazepine Price by Type (2027-2032) & (US$/Unit)
Table 177. Global Oxcarbazepine Sales by Application (2021-2026) & (K Units)
Table 178. Global Oxcarbazepine Sales by Application (2027-2032) & (K Units)
Table 179. Global Oxcarbazepine Sales Market Share by Application (2021-2026)
Table 180. Global Oxcarbazepine Sales Market Share by Application (2027-2032)
Table 181. Global Oxcarbazepine Revenue by Application (2021-2026) & (US$ Million)
Table 182. Global Oxcarbazepine Revenue by Application (2027-2032) & (US$ Million)
Table 183. Global Oxcarbazepine Revenue Market Share by Application (2021-2026)
Table 184. Global Oxcarbazepine Revenue Market Share by Application (2027-2032)
Table 185. Global Oxcarbazepine Price by Application (2021-2026) & (US$/Unit)
Table 186. Global Oxcarbazepine Price by Application (2027-2032) & (US$/Unit)
Table 187. Key Raw Materials
Table 188. Raw Materials Key Suppliers
Table 189. Oxcarbazepine Distributors List
Table 190. Oxcarbazepine Customers List
Table 191. Oxcarbazepine Industry Trends
Table 192. Oxcarbazepine Industry Drivers
Table 193. Oxcarbazepine Industry Restraints
Table 194. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Oxcarbazepine Product Image
Figure 5. Global Oxcarbazepine Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Oxcarbazepine Market Size (2021-2032) & (US$ Million)
Figure 7. Global Oxcarbazepine Sales (2021-2032) & (K Units)
Figure 8. Global Oxcarbazepine Average Price (US$/Unit) & (2021-2032)
Figure 9. Tablets (150mg, 300mg, 600mg) Product Image
Figure 10. Oral Suspension Product Image
Figure 11. Pediatric Use (Aged 2-4 years, 4-16 years) Product Image
Figure 12. Adult Use Product Image
Figure 13. Global Oxcarbazepine Revenue Share by Manufacturers in 2025
Figure 14. Global Manufacturers of Oxcarbazepine, Manufacturing Sites & Headquarters
Figure 15. Global Top 5 and 10 Oxcarbazepine Players Market Share by Revenue in 2025
Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 17. Global Oxcarbazepine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 18. Global Oxcarbazepine Sales by Region in 2025
Figure 19. Global Oxcarbazepine Revenue by Region in 2025
Figure 20. North America Oxcarbazepine Market Size by Country in 2025
Figure 21. North America Oxcarbazepine Sales Market Share by Country (2021-2032)
Figure 22. North America Oxcarbazepine Revenue Market Share by Country (2021-2032)
Figure 23. United States Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 24. Canada Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Europe Oxcarbazepine Market Size by Country in 2025
Figure 26. Europe Oxcarbazepine Sales Market Share by Country (2021-2032)
Figure 27. Europe Oxcarbazepine Revenue Market Share by Country (2021-2032)
Figure 28. Germany Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. France Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. U.K. Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Italy Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Netherlands Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Nordic Countries Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Asia Pacific Oxcarbazepine Market Size by Country in 2025
Figure 35. Asia Pacific Oxcarbazepine Sales Market Share by Country (2021-2032)
Figure 36. Asia Pacific Oxcarbazepine Revenue Market Share by Country (2021-2032)
Figure 37. China Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Japan Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. South Korea Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. India Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Australia Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. China Taiwan Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Southeast Asia Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South America Oxcarbazepine Market Size by Country in 2025
Figure 46. South America Oxcarbazepine Sales Market Share by Country (2021-2032)
Figure 47. South America Oxcarbazepine Revenue Market Share by Country (2021-2032)
Figure 48. Mexico Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Brazil Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Argentina Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Middle East and Africa Oxcarbazepine Market Size by Country in 2025
Figure 52. Middle East and Africa Oxcarbazepine Sales Market Share by Country (2021-2032)
Figure 53. Middle East and Africa Oxcarbazepine Revenue Market Share by Country (2021-2032)
Figure 54. Turkey Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Saudi Arabia Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. UAE Oxcarbazepine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Global Oxcarbazepine Sales Market Share by Type (2021-2032)
Figure 58. Global Oxcarbazepine Revenue Market Share by Type (2021-2032)
Figure 59. Global Oxcarbazepine Price (US$/Unit) by Type (2021-2032)
Figure 60. Global Oxcarbazepine Sales Market Share by Application (2021-2032)
Figure 61. Global Oxcarbazepine Revenue Market Share by Application (2021-2032)
Figure 62. Global Oxcarbazepine Price (US$/Unit) by Application (2021-2032)
Figure 63. Oxcarbazepine Value Chain
Figure 64. Oxcarbazepine Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Oxcarbazepine Industry Opportunities and Challenges
提及公司
Sihuan PharmHumanwell HealthcareNovartis (Trileptal)MylanHuikang PharmaceuticalTeva PharmaceuticalTaro PharmaceuticalsSupernus Pharmaceuticals (Oxtellar XR)Sun PharmStada GroupRoxane LaboratoriesRanbaxy PharmaceuticalsOrion CorporationNobelpharmaNexgen pharmaNeuraxpharmJubilant GenericsJamp PharmaHikma PharmaceuticalsGlenmark PharmaceuticalsApotexANI PharmaceuticalsAmneal Pharmaceuticals
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們